1. Home
  2. ALT vs NBR Comparison

ALT vs NBR Comparison

Compare ALT & NBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • NBR
  • Stock Information
  • Founded
  • ALT 1997
  • NBR 1952
  • Country
  • ALT United States
  • NBR Bermuda
  • Employees
  • ALT N/A
  • NBR N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • NBR Oil & Gas Production
  • Sector
  • ALT Health Care
  • NBR Energy
  • Exchange
  • ALT Nasdaq
  • NBR Nasdaq
  • Market Cap
  • ALT 472.3M
  • NBR 523.7M
  • IPO Year
  • ALT N/A
  • NBR N/A
  • Fundamental
  • Price
  • ALT $5.28
  • NBR $39.05
  • Analyst Decision
  • ALT Strong Buy
  • NBR Hold
  • Analyst Count
  • ALT 8
  • NBR 6
  • Target Price
  • ALT $20.83
  • NBR $79.40
  • AVG Volume (30 Days)
  • ALT 2.5M
  • NBR 463.5K
  • Earning Date
  • ALT 05-08-2025
  • NBR 04-23-2025
  • Dividend Yield
  • ALT N/A
  • NBR N/A
  • EPS Growth
  • ALT N/A
  • NBR N/A
  • EPS
  • ALT N/A
  • NBR N/A
  • Revenue
  • ALT $20,000.00
  • NBR $2,930,126,000.00
  • Revenue This Year
  • ALT N/A
  • NBR $6.68
  • Revenue Next Year
  • ALT N/A
  • NBR $6.72
  • P/E Ratio
  • ALT N/A
  • NBR N/A
  • Revenue Growth
  • ALT N/A
  • NBR N/A
  • 52 Week Low
  • ALT $5.15
  • NBR $34.42
  • 52 Week High
  • ALT $11.50
  • NBR $105.96
  • Technical
  • Relative Strength Index (RSI)
  • ALT 38.48
  • NBR 38.27
  • Support Level
  • ALT $5.15
  • NBR $36.91
  • Resistance Level
  • ALT $6.09
  • NBR $42.89
  • Average True Range (ATR)
  • ALT 0.42
  • NBR 3.15
  • MACD
  • ALT -0.05
  • NBR 0.40
  • Stochastic Oscillator
  • ALT 24.54
  • NBR 48.15

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About NBR Nabors Industries Ltd.

Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and innovative technologies. It has operations in over 15 countries, 291 actively marketed rigs for land-based drilling operations and 28 actively marketed rigs for offshore platform drilling operations in the United States and multiple international markets. The company has five reportable segments: U.S. Drilling, Canada Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.

Share on Social Networks: